SPX6,812.45▲ 0.42%NDX24,310▲ 0.88%DJI47,121▼ 0.12%RUT2,418.90▼ 0.35%VIX17.82▼ 3.10%NVDA168.40▼ 9.20%AAPL246.15▲ 0.61%MSFT498.30▼ 2.40%TSLA412.70▲ 1.90%BE38.25▲ 4.70%UNG14.06▼ 1.20%/CL71.34▲ 0.80%/GC3,988.10▲ 0.35%BTC101,240▲ 1.15%10Y4.27▲ 0.05%DXY99.12▼ 0.18%SPX6,812.45▲ 0.42%NDX24,310▲ 0.88%DJI47,121▼ 0.12%RUT2,418.90▼ 0.35%VIX17.82▼ 3.10%NVDA168.40▼ 9.20%AAPL246.15▲ 0.61%MSFT498.30▼ 2.40%TSLA412.70▲ 1.90%BE38.25▲ 4.70%UNG14.06▼ 1.20%/CL71.34▲ 0.80%/GC3,988.10▲ 0.35%BTC101,240▲ 1.15%10Y4.27▲ 0.05%DXY99.12▼ 0.18%
PD

Phil's posts

Phil Davis

Founder & Chief Strategist

Hedge fund manager, Forbes' "Top Stock Picker" and the voice behind PSW's daily morning reports, Top Trade Alerts and live portfolio reviews. His motto: be the house, not the gambler.

Posts
28
Trade alerts
4

1 post · Article · Biotech

Biotech Investing Trends Worth Trading Now
ArticleTechnical Analysis

Biotech Investing Trends Worth Trading Now

Biotech investing trends are shifting toward proven science, deal premiums, obesity drugs, and catalyst-driven trades. Here is how investors can position.

Phil Davis